US Patent Issued to University of Virginia Patent Foundation on Nov. 25 for "Compositions and methods for predicting lung function decline in idiopathic pulmonary fibrosis" (Virginia Inventor)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,960, issued on Nov. 25, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.).

"Compositions and methods for predicting lung function decline in idiopathic pulmonary fibrosis" was invented by Imre Noth (Charlottesville, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for generating prognostic signatures for subject diagnosed with Idiopathic Pulmonary Fibrosis (IPF) with respect to decline in lung Forced Vital Capacity (FVC). The methods can include determining first expression levels for one or more genes as set forth herein in a first biological sample obtained from a subject diagnosed with IPF, det...